Skip to main content

Fallopian Tube

  • Chapter
  • 1500 Accesses

Abstract

Neoplastic or reactive lesions presenting at the fallopian tube as a primary site of involvement are uncommon. The fallopian tube is most often received for intraoperative frozen section evaluation as part of a salpingo-oophorectomy specimen. The primary disease site may not always be accurately determined by preoperative imaging studies or the surgeon’s intraoperative assessment, and the specimen sent to pathology as an ovarian/adnexal mass occasionally may reveal a primary fallopian tube disease process. The most common primary fallopian tube lesions include epithelial neoplasms—benign, borderline, or malignant—embryonal remnants and cysts (e.g., paratubal cyst), endometriosis, inflammatory conditions, and ectopic pregnancy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Bossuyt V, Medeiros F, Drapkin R, Folkins AK, Crum CP, Nucci MR. Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma. Int J Gynecol Pathol. 2008;27:390–7.

    Article  PubMed  Google Scholar 

  2. Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol. 2006;30:1222–30.

    Article  PubMed  Google Scholar 

  3. Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25:3985–90.

    Article  PubMed  Google Scholar 

  4. Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009;33:1125–36.

    Article  PubMed  Google Scholar 

  5. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, et al. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011;21:846–51.

    Article  PubMed  Google Scholar 

  6. Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation. Gynecol Oncol. 2011;121:466–71.

    Article  PubMed  Google Scholar 

  7. Wethington SL, Park KJ, Soslow RA, Kauff ND, Brown CL, Dao F, et al. Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). Int J Gynecol Cancer. 2013;23:1603–11.

    Article  PubMed  Google Scholar 

  8. Powell CB, Swisher EM, Cass I, McLennan J, Morquist B, Garcia RL, et al. Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol. 2013;129:364–71.

    Article  CAS  PubMed  Google Scholar 

  9. Kurman RJ, Vang R, Junge J, Hannibal CG, Kjaer SK, Shih IM. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol. 2011;35:1605–14.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Farquhar CM. Ectopic pregnancy. Lancet. 2005;366:583–91.

    Article  PubMed  Google Scholar 

  11. Marcus SF, Macnamee M, Brinsden P. Heterotopic pregnancies after in-vitro fertilization and embryo transfer. Hum Reprod. 1995;10:1232–6.

    Article  CAS  PubMed  Google Scholar 

  12. Falcone T, Mascha EJ, Goldberg JM, Falconi LL, Mohla G, Attaran M. A study of risk factors for ruptured tubal ectopic pregnancy. J Womens Health. 1998;7:459–63.

    Article  CAS  PubMed  Google Scholar 

  13. Roukos DH, Briasoulis E. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome. Nat Clin Pract Oncol. 2007;4:578–90.

    Article  CAS  PubMed  Google Scholar 

  14. Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58–64.

    Article  CAS  PubMed  Google Scholar 

  15. Lee Y, Medeiros F, Kindelberger D, Callahan MJ, Muto MG, Crum CP. Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol. 2006;13:1–7.

    Article  PubMed  Google Scholar 

  16. Gwin K, Wilcox R, Montag A. Insights into selected genetic diseases affecting the female reproductive tract and their implication for pathologic evaluation of gynecologic specimens. Arch Pathol Lab Med. 2009;133:1041–52.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hui, P., Buza, N. (2015). Fallopian Tube. In: Atlas of Intraoperative Frozen Section Diagnosis in Gynecologic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-21807-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21807-6_7

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21806-9

  • Online ISBN: 978-3-319-21807-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics